Regional expansion Kalbe Farma is expanding its pharmaceutical and healthcare footprint across Indonesia and Southeast Asia, with recent office expansions and a growing international presence in ASEAN, Nigeria, and South Africa. Sales teams can target distributors and hospital networks in these expanding markets and propose integrated healthcare solutions spanning prescription drugs, consumer health, and nutritionals.

Diversified divisions The company operates four divisions—Prescription Pharmaceutical, Consumer Health, Nutritionals, and Distribution and Logistics—creating cross-sell opportunities for bundled offerings, co-branded consumer wellness campaigns, and end-to-end supply chain solutions to retailers and healthcare providers.

R&D momentum Kalbe maintains robust R&D activities in generic drug formulations and innovative consumer and nutritional products, with partnerships on cancer therapies and biotech research. This signals potential for strategic collaborations, licensing deals, or contract research and manufacturing services for new drug candidates or specialty nutrition products.

Strong market position As the largest publicly-listed Indonesian pharmaceutical company with extensive distribution to over one million outlets, Kalbe offers substantial scale, branding, and logistical capabilities, making it an attractive partner for distributors, contract manufacturing, and regional sales partnerships to accelerate market access.

Recent product launches Kalbe’s recent launches, such as Proten Plus Advanced Nutrition Drink and Serplulimab lung cancer therapy, indicate a focus on advanced nutrition and oncology. This creates opportunities for sponsorships, clinical education, hospital partnerships, and multi-channel marketing collaborations around new high-growth product categories.